Explore FHI 360

Practice Area

Research

There is an art to improving lives. And it’s in our science.

Published research

Women’s experience receiving drug feedback and adherence counseling in MTN-025/HOPE-an HIV prevention open-label trial of the dapivirine vaginal ring

Event

FHI 360 at the International Conference on Family Planning 2022

FHI 360 is pleased to join the global community of family planning and sexual and reproductive health experts at the International Conference on Family Planning (ICFP) 2022. For over 50 years, FHI 360 has been providing cutting-edge leadership in...

Published research

Does the ring work? Perceptions and understanding of the efficacy of a dapivirine vaginal ring for HIV prevention amongst women in a placebo-controlled trial

Published research

Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: A multicenter phase 3 trial

Published research

Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa

Tools

Updated Couple Years of Protection: Literature Review, Guidance for Updating Existing Methods, and Adding New Methods

This couple years of protection (CYP) brief synthesizes findings relevant to CYP for USAID and includes background information about the CYP development and revision process for the family planning field.

Published research

Behavioral effects of different contraceptive methods and HIV acquisition: An ancillary study of the ECHO randomized trial

Published research

Task Sharing of injectable contraception services in Pakistan: A randomized controlled trial

Published research

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Research

Women’s experience receiving drug feedback and adherence counseling in MTN-025/HOPE-an HIV prevention open-label trial of the dapivirine vaginal ring

FHI 360 at the International Conference on Family Planning 2022

Does the ring work? Perceptions and understanding of the efficacy of a dapivirine vaginal ring for HIV prevention amongst women in a placebo-controlled trial

Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: A multicenter phase 3 trial

Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa

Updated Couple Years of Protection: Literature Review, Guidance for Updating Existing Methods, and Adding New Methods

Behavioral effects of different contraceptive methods and HIV acquisition: An ancillary study of the ECHO randomized trial

Task Sharing of injectable contraception services in Pakistan: A randomized controlled trial

Optimizing the design of a contraceptive microarray patch: a discrete choice experiment on women’s preferences in India and Nigeria

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

33 Results Found